Loading...

Secular Trends And Cell Therapies Will Expand Markets Despite Risks

Published
17 Apr 25
Updated
07 May 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-50.5%
7D
-7.0%

Author's Valuation

US$17.6538.1% undervalued intrinsic discount

AnalystHighTarget Fair Value